US · guidance
CMS SOM App. J, Tag W314
§483.450(e)(4) in conjunction with the physician and the drug regimen review requirement at
§483.460(j),
Guidance §483.450(e)(4)
The physician and pharmacist must regularly review use of drugs for control of inappropriate
behavior for their effectiveness in changing the targeted behavior/symptoms, untoward side
effects, contraindications for continued use, and communicate this information to relevant staff.
History
Rev. 135, Issued: 02-27-15, Effective: 04-27-15, Implementation: 04-27-15
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
ee827db54afef58a080099c7ff5a285ac5d6950d217241ad0e11a872aa56b0b3
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.